1. Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine.
- Author
-
Jansen J, Friesema EC, Kester MH, Milici C, Reeser M, Grüters A, Barrett TG, Mancilla EE, Svensson J, Wemeau JL, Busi da Silva Canalli MH, Lundgren J, McEntagart ME, Hopper N, Arts WF, and Visser TJ
- Subjects
- Cell Line, Tumor, Codon, Nonsense, Gene Deletion, Genetic Diseases, X-Linked metabolism, Humans, Intellectual Disability metabolism, Neurons metabolism, Point Mutation, Psychomotor Disorders metabolism, RNA Splice Sites, Symporters, Transfection, Triiodothyronine pharmacokinetics, Genetic Diseases, X-Linked genetics, Intellectual Disability genetics, Monocarboxylic Acid Transporters genetics, Psychomotor Disorders genetics, Triiodothyronine blood
- Abstract
Context: T(3) action in neurons is essential for brain development. Recent evidence indicates that monocarboxylate transporter 8 (MCT8) is important for neuronal T(3) uptake. Hemizygous mutations have been identified in the X-linked MCT8 gene in boys with severe psychomotor retardation and elevated serum T(3) levels., Objective: The objective of this study was to determine the functional consequences of MCT8 mutations regarding transport of T(3)., Design: MCT8 function was studied in wild-type or mutant MCT8-transfected JEG3 cells by analyzing: 1) T(3) uptake, 2) T(3) metabolism in cells cotransfected with human type 3 deiodinase, 3) immunoblotting, and 4) immunocytochemistry., Results: The mutations identified in MCT8 comprise four deletions (24.5 kb, 2.4 kb, 14 bp, and 3 bp), three missense mutations (Ala224Val, Arg271His, and Leu471Pro), a nonsense mutation (Arg245stop), and a splice site mutation (94 amino acid deletion). All tested mutants were inactive in uptake and metabolism assays, except MCT8 Arg271His, which showed approximately 20% activity vs. wild-type MCT8., Conclusion: These findings support the hypothesis that the severe psychomotor retardation and elevated serum T(3) levels in these patients are caused by inactivation of the MCT8 transporter, preventing action and metabolism of T(3) in central neurons.
- Published
- 2007
- Full Text
- View/download PDF